Top

Published in:

01-05-2016 | Erratum

Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment

Authors: Dimitrios Mathios, Jacob Ruzevick, Christopher M. Jackson, Haiying Xu, Sagar R. Shah, Janis M. Taube, Peter C. Burger, Edward F. McCarthy, Alfredo Quinones-Hinojosa, Drew M. Pardoll, Michael Lim

Published in: Journal of Neuro-Oncology | Issue 1/2016

Excerpt

The fifth author’s name was incomplete in the original publication. It shows correctly in this erratum. …

Title: Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
Authors: Dimitrios Mathios
Jacob Ruzevick
Christopher M. Jackson
Haiying Xu
Sagar R. Shah
Janis M. Taube
Peter C. Burger
Edward F. McCarthy
Alfredo Quinones-Hinojosa
Drew M. Pardoll
Michael Lim
Publication date: 01-05-2016
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 1/2016
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-016-2130-0

At a glance: The STEP trials

Springer Medicine

Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2016

Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study

Preservation of KIT genotype in a novel pair of patient-derived orthotopic xenograft mouse models of metastatic pediatric CNS germinoma

Vestibular schwannoma and pituitary adenoma in the same patient: coincidence or novel clinical association?

Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study

Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids

Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial